Search in:

Expert Opinion on Biological Therapy Volume 8, 2008 - Issue 4

Submit an article Journal homepage

156

Views

CrossRef citations to date

Altmetric

Drug Evaluations

Augmentation therapy in α-1 antitrypsin deficiency

Gustavo A Heresi Fellow Respiratory Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA

, MD &

James K Stoller Jean Wall Bennett Professor of Medicine, Executive Director, Leadership Development, Cleveland Clinic and Head Cleveland Clinic Lerner College of Medicine, Respiratory Institute, Cleveland Clinic Respiratory Therapy, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA +1 216 444 1960; +1 216 445 8160; [email protected]

, MD MS

Pages 515-526 | Published online: 19 Mar 2008

Cite this article
https://doi.org/10.1517/14712598.8.4.515

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Wood AM, Stockley RA. Alpha one antitrypsin deficiency: from gene to treatment. Respiration 2007;74:481-92
PubMed Web of Science ®Google Scholar
Stoller JK, Aboussouan LS. α1-antitrypsin deficiency. Lancet 2005;365:2225-36
PubMed Web of Science ®Google Scholar
Laurell CB EA. The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-40
Web of Science ®Google Scholar
Luisetti M, Seersholm N. α1-antitrypsin deficiency. 1: epidemiology of α1-antitrypsin deficiency. Thorax 2004;59:164-9
PubMed Web of Science ®Google Scholar
DeMeo DL, Silverman EK. α1-antitrypsin deficiency. 2: genetic aspects of α1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 2004;59:259-64
PubMed Web of Science ®Google Scholar
Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 2004;350:2689-97
PubMed Web of Science ®Google Scholar
Brantly M. α1-antitrypsin: not just an antiprotease: extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol. Am J Respir Cell Mol Biol 2002;27:652-4
PubMed Web of Science ®Google Scholar
Stoller JK. Clinical features and natural history of severe α1-antitrypsin deficiency. Roger S. Mitchell Lecture. Chest 1997;111:S123-8
PubMed Web of Science ®Google Scholar
Hubbard RC, Crystal RG. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency. Am J Med 1988;84:52-62
PubMed Web of Science ®Google Scholar
Gadek JE, Klein HG, Holland PV, Crystal RG. Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest 1981;68:1158-65
PubMed Web of Science ®Google Scholar
Juvelekian GS, Stoller JK. Augmentation therapy for α1-antitrypsin deficiency. Drugs 2004;64:1743-56
PubMed Web of Science ®Google Scholar
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900
PubMed Web of Science ®Google Scholar
Coan MH, Brockway WJ, Eguizabal H, et al. Preparation and properties of alpha 1-proteinase inhibitor concentrate from human plasma. Vox Sang 1985;48:333-42
PubMed Web of Science ®Google Scholar
Carrell RW, Lomas DA. Alpha1-antitrypsin deficiency – a model for conformational diseases. N Engl J Med 2002;346:45-53
PubMed Web of Science ®Google Scholar
Mornex JF, Chytil-Weir A, Martinet Y, et al. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J Clin Invest 1986;77:1952-61
PubMed Web of Science ®Google Scholar
Venembre P, Boutten A, Seta N, et al. Secretion of alpha 1-antitrypsin by alveolar epithelial cells. FEBS Lett 1994;346:171-4
PubMed Web of Science ®Google Scholar
Lomas DA, Mahadeva R. α1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002;110:1585-90
PubMed Web of Science ®Google Scholar
Wilczynska M, Fa M, Karolin J, et al. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat Struct Biol 1997;4:354-7
PubMedGoogle Scholar
Elliott PR, Lomas DA, Carrell RW, Abrahams JP. Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat Struct Biol 1996;3:676-81
PubMedGoogle Scholar
Gadek JE, Fells GA, Zimmerman RL, et al. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest 1981;68:889-98
PubMed Web of Science ®Google Scholar
Huntington JA, Read RJ, Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000;407:923-6
PubMed Web of Science ®Google Scholar
Eriksson S. A 30-year perspective on α1-antitrypsin deficiency. Chest 1996;110:S237-42
PubMed Web of Science ®Google Scholar
Churg A, Dai J, Zay K, et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest 2001;81:1119-31
PubMed Web of Science ®Google Scholar
Spencer LT, Paone G, Krein PM, et al. Role of human neutrophil peptides in lung inflammation associated with α1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol 2004;286:L514-520
PubMed Web of Science ®Google Scholar
Aldonyte R, Jansson L, Janciauskiene S. Concentration-dependent effects of native and polymerised α1-antitrypsin on primary human monocytes, in vitro. BMC Cell Biol 2004;5:11. Published online 29 March 2004, doi:10.1186/1471-2121-5-11
PubMedGoogle Scholar
Janciauskiene S, Larsson S, Larsson P, et al. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1-antitrypsin. Biochem Biophys Res Commun 2004;321:592-600
PubMed Web of Science ®Google Scholar
Dafforn TR, Mahadeva R, Elliott PR, et al. A kinetic mechanism for the polymerization of α1-antitrypsin. J Biol Chem 1999;274:9548-55
PubMed Web of Science ®Google Scholar
Devlin GL, Chow MK, Howlett GJ, Bottomley SP. Acid Denaturation of alpha1-antitrypsin: characterization of a novel mechanism of serpin polymerization. J Mol Biol 2002;324:859-70
PubMed Web of Science ®Google Scholar
Sivasothy P, Dafforn TR, Gettins PG, Lomas DA. Pathogenic α1-antitrypsin polymers are formed by reactive loop-β-sheet A linkage. J Biol Chem 2000;275:33663-8
PubMed Web of Science ®Google Scholar
Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z α1-antitrypsin accumulation in the liver. Nature 1992;357:605-7
PubMed Web of Science ®Google Scholar
Wewers MD, Casolaro MA, Sellers SE, et al. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055-62
PubMed Web of Science ®Google Scholar
Hubbard RC, Sellers S, Czerski D, et al. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency. JAMA 1988;260:1259-64
PubMed Web of Science ®Google Scholar
Barker AF, Iwata-Morgan I, Oveson L, Roussel R. Pharmacokinetic study of α1-antitrypsin infusion in α1-antitrypsin deficiency. Chest 1997;112:607-13
PubMed Web of Science ®Google Scholar
Stoller JK, Rouhani F, Brantly M, et al. Biochemical efficacy and safety of a new pooled human plasma α1-antitrypsin, Respitin. Chest 2002;122:66-74
PubMed Web of Science ®Google Scholar
Stocks JM, Brantly M, Pollock D, et al. Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira. Copd 2006;3:17-23
PubMedGoogle Scholar
Seersholm N, Wencker M, Banik N, et al. Does α1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary α1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 1997;10:2260-3
PubMed Web of Science ®Google Scholar
Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1998;158:49-59
PubMed Web of Science ®Google Scholar
Lieberman J. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Chest 2000;118:1480-5
PubMed Web of Science ®Google Scholar
Gottlieb DJ, Luisetti M, Stone PJ, et al. Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group. Am J Respir Crit Care Med 2000;162:2069-72
PubMed Web of Science ®Google Scholar
Wencker M, Fuhrmann B, Banik N, Konietzko N. Longitudinal follow-up of patients with α1-protease inhibitor deficiency before and during therapy with IV α1-protease inhibitor. Chest 2001;119:737-44
PubMed Web of Science ®Google Scholar
Stockley RA, Bayley DL, Unsal I, Dowson LJ. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2002;165:1494-8
PubMed Web of Science ®Google Scholar
Dirksen A, Dijkman JH, Madsen F, et al. A randomized clinical trial of α1-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160:1468-72
PubMed Web of Science ®Google Scholar
Stone PJ, Morris TA 3rd, Franzblau C, Snider GL. Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha-1-antitrypsin-deficient humans. Respiration 1995;62:76-9
PubMed Web of Science ®Google Scholar
Wencker M, Banik N, Buhl R, et al. Long-term treatment of α1-antitrypsin deficiency-related pulmonary emphysema with human α1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Eur Respir J 1998;11:428-33
PubMed Web of Science ®Google Scholar
Stoller JK, Fallat R, Schluchter MD, et al. Augmentation therapy with α1-antitrypsin: patterns of use and adverse events. Chest 2003;123:1425-34
PubMed Web of Science ®Google Scholar
Hay JW, Robin ED. Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease. Am J Public Health 1991;81:427-33
PubMed Web of Science ®Google Scholar
Alkins SA, O'Malley P. Should health-care systems pay for replacement therapy in patients with α1-antitrypsin deficiency? A critical review and cost-effectiveness analysis. Chest 2000;117:875-80
PubMed Web of Science ®Google Scholar
Gildea TR, Shermock KM, Singer ME, Stoller JK. Cost-effectiveness analysis of augmentation therapy for severe α1-antitrypsin deficiency. Am J Respir Crit Care Med 2003;167:1387-92
PubMed Web of Science ®Google Scholar
Abboud RT, Ford GT, Chapman KR. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society. Can Respir J 2001;8:81-8
PubMedGoogle Scholar
Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978;204:345-51
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Augmentation therapy in α-1 antitrypsin deficiency

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Augmentation therapy in α-1 antitrypsin deficiency

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date